Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-461 in Advanced Melanoma
NCT00060710Phase 2Terminated
- Sponsor
- Astellas Pharma
- Start
- Jan 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of CP-461 in Malignant Melanoma (MM), sponsored by Astellas Pharma. Started Jan 2003; status: terminated.
02
Drugs
CP-461
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00060710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060710.